Advanced Search

Oncology & Hematology Coding Alert

Reader Questions:

Stay Immune to This Antineoplastic Coding Error

Published on Mon Jul 26, 2021

Question: When would you use Z51.12? Is it appropriate to use this code for patients receiving immunotherapy for conditions such as hypogammaglobulinemia, common variable immunodeficiency, or sarcoidosis? AAPC Forum Participant Answer: You would use Z51.12 (Encounter for antineoplastic immunotherapy) to document therapy intended for strengthening the patient’s immune system to fight cancer. However, the conditions you mention are conditions of [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All